3-(Methoxymethoxy)-2,6-dimethylaniline, 100mg

Obiettivo Plan PLPH 20x/0,40 per contrasto di fase

N-(3-Bromopropyl)phthalimide, 98.0%, 10g

1,3-Benzenedimethanamine, 95.0%, 100g

2,6-Dihydroxy-4-methylbenzoic acid monohydrate, 99.0%, 1g

tert-Butyl (3R)-3-{4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl}piperidine-1-carboxylate, 98%, 10g

Ethyl 3-hydrazinobenzoate hydrochloride, 95.0%, 1g

2-(3,5-Dimethyl-pyrazol-1-yl)-ethylamine, 97.0%, 2g

2-Aminothiazole-5-carboxamide, 95.0%, 250mg

2-Bromo-3-chlorobenzoic acid, 95.0%, 1g

5-Bromo-2,3,3-trimethyl-3H-pyrrolo[2,3-b]pyridine, 97.0%, 25g

5-Cyclopropylnicotinic acid, 95.0%, 100mg

3-(4-Ethylphenyl)-1-propene, 97.0%, 5g